BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2668339)

  • 1. Perverted priorities. The physician/scientist as spokesman and salesman for biomedical research. Presidential address to the American Society for Clinical Investigation, Washington, DC, 29 April 1989.
    Kahn CR
    J Clin Invest; 1989 Sep; 84(3):723-7. PubMed ID: 2668339
    [No Abstract]   [Full Text] [Related]  

  • 2. A lost generation.
    Weinberg RA
    Cell; 2006 Jul; 126(1):9-10. PubMed ID: 16839866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating translational research.
    Laurence J
    Transl Res; 2006 Jul; 148(1):1-3. PubMed ID: 16887490
    [No Abstract]   [Full Text] [Related]  

  • 4. Windfall warning.
    Nature; 2009 Oct; 461(7266):847-8. PubMed ID: 19829323
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing the decline in NIH pain research funding.
    Max MB
    J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769
    [No Abstract]   [Full Text] [Related]  

  • 6. Increasing R01 competition concerns researchers.
    Vastag B
    J Natl Cancer Inst; 2006 Oct; 98(20):1436-8. PubMed ID: 17047187
    [No Abstract]   [Full Text] [Related]  

  • 7. Research funding. NIH in the post-doubling era: realities and strategies.
    Zerhouni EA
    Science; 2006 Nov; 314(5802):1088-90. PubMed ID: 17110557
    [No Abstract]   [Full Text] [Related]  

  • 8. The future of academic health centers.
    Shine KI
    Physiologist; 1995 Apr; 38(2):51-5. PubMed ID: 7784499
    [No Abstract]   [Full Text] [Related]  

  • 9. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 10. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the stimulus working for you?
    Freeman R; Block F; Greenberg D; Levi M; Segal AM; Crow M; Teitelbaum MS
    Nature; 2009 Oct; 461(7266):876-8. PubMed ID: 19829353
    [No Abstract]   [Full Text] [Related]  

  • 12. Nurturing the biomedical research enterprise.
    Wyngaarden JB
    P R Health Sci J; 1986 Aug; 5(2):43-50. PubMed ID: 3823360
    [No Abstract]   [Full Text] [Related]  

  • 13. NIH: gearing up for the twenty-first century.
    Baldwin W; McCardle P
    Physiologist; 1997 Jun; 40(3):89, 91-3. PubMed ID: 9230629
    [No Abstract]   [Full Text] [Related]  

  • 14. Science and politics: a fatal mix?
    Joachim C
    Nat Mater; 2004 Jul; 3(7):416. PubMed ID: 15229483
    [No Abstract]   [Full Text] [Related]  

  • 15. Sunny outlook for Australian science.
    Pincock S
    Nature; 2009 May; 459(7245):304-5. PubMed ID: 19458676
    [No Abstract]   [Full Text] [Related]  

  • 16. StatBite: Stimulus funding: where does the NCI propose to invest?
    J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19679852
    [No Abstract]   [Full Text] [Related]  

  • 17. Revitalizing the federal commitment in support of biomedical research.
    Hathaway DR
    Clin Res; 1988 Sep; 36(5):475-82. PubMed ID: 3168401
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic issues in defining stable funding levels for HIV/AIDS research.
    Eastaugh SR
    J Health Adm Educ; 1992; 10(1):139-49. PubMed ID: 10118035
    [No Abstract]   [Full Text] [Related]  

  • 19. Funding of biomedical research in New Zealand.
    Richards AM
    N Z Med J; 2000 Sep; 113(1118):400-3. PubMed ID: 11062816
    [No Abstract]   [Full Text] [Related]  

  • 20. Why French politics and science don't mix.
    Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.